Skip to main content

Table 2 General clinical features of mitochondrial diabetes

From: Analysis of association among clinical features and shorter leukocyte telomere length in mitochondrial diabetes with m.3243A>G mitochondrial DNA mutation

 

Mitochondrial diabetes (n = 15)

Age (year)

35.0 ± 14.6

Gender (F/M)

12:3

Disease Duration (year)

4.00 ± 2.54

BMI (kg/m2)

19.5 ± 2.36

HbA1c (%)

6.42 ± 1.01

Fasting blood glucose (mmol/L)

7.75 ± 2.03

Fasting insulin (μIU/ml)

5.23 ± 3.26

Fasting C-peptide (ng/ml)

0.53 ± 0.37

HOMA-IR

1.63 ± 0.81

HOMA-IS

0.03 ± 0.02

Diabetes treatment

7:8

(Insulin: oral hypoglycemic medication)

(5 probands all received insulin therapy)

  1. BMI body mass index, HOMA-IR fasting plasma glucose (mmol/L) *fasting insulin (μIU/ml)/22.5, HOMA-IS 1/fasting plasma glucose (mmol/L) *fasting insulin (μIU/ml)